PortfoliosLab logoPortfoliosLab logo
NVO vs. ^GSPC
Performance
Return for Risk
Drawdowns
Volatility

Performance

NVO vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and S&P 500 Index (^GSPC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVO achieves a 0.91% return, which is significantly lower than ^GSPC's 8.73% return. Over the past 10 years, NVO has underperformed ^GSPC with an annualized return of 8.18%, while ^GSPC has yielded a comparatively higher 13.09% annualized return.


NVO

1D
-1.41%
1M
14.86%
6M
-17.63%
YTD
0.91%
1Y
-19.26%
3Y*
-13.51%
5Y*
4.43%
10Y*
8.18%
ALL TIME*
14.52%

^GSPC

1D
-0.19%
1M
-0.76%
6M
7.25%
YTD
8.73%
1Y
18.21%
3Y*
17.95%
5Y*
11.30%
10Y*
13.09%
ALL TIME*
8.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVO vs. ^GSPC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NVO
Novo Nordisk A/S
0.91%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%
^GSPC
S&P 500 Index
8.73%16.39%23.31%24.23%-19.44%26.89%16.26%28.88%-6.24%19.42%

Correlation

The correlation between NVO and ^GSPC is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.36

Correlation (3Y)
Calculated over the trailing 3-year period

0.33

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jan 4, 1982

0.32

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVO vs. ^GSPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO
NVO Risk / Return Rank: 3030
Overall Rank
NVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2929
Sortino Ratio Rank
NVO Omega Ratio Rank: 2929
Omega Ratio Rank
NVO Calmar Ratio Rank: 3232
Calmar Ratio Rank
NVO Martin Ratio Rank: 3333
Martin Ratio Rank

^GSPC
^GSPC Risk / Return Rank: 6767
Overall Rank
^GSPC Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
^GSPC Sortino Ratio Rank: 6363
Sortino Ratio Rank
^GSPC Omega Ratio Rank: 6767
Omega Ratio Rank
^GSPC Calmar Ratio Rank: 6161
Calmar Ratio Rank
^GSPC Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVO vs. ^GSPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVO^GSPCDifference
Sharpe ratioReturn per unit of total volatility

-1.83

Sortino ratioReturn per unit of downside risk

-2.21

Omega ratioGain probability vs. loss probability

0.97

1.26

-0.29

Calmar ratioReturn relative to maximum drawdown

-0.39

2.01

-2.40

Martin ratioReturn relative to average drawdown

-0.61

8.68

-9.29

NVO vs. ^GSPC - Sharpe Ratio Comparison

The current NVO Sharpe Ratio is -0.37, which is lower than the ^GSPC Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of NVO and ^GSPC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVO vs. ^GSPC - Drawdown Comparison

The maximum NVO drawdown since its inception was -74.70%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for NVO and ^GSPC.


Loading charts...

Drawdown Indicators


NVO^GSPCDifference

Max Drawdown

Largest peak-to-trough decline

-74.70%

-56.78%

-17.92%

Max Drawdown (1Y)

Largest decline over 1 year

-49.17%

-9.10%

-40.07%

Max Drawdown (3Y)

Largest decline over 3 years

-74.70%

-18.90%

-55.80%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

-25.43%

-49.27%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

-33.92%

-40.78%

Current Drawdown

Current decline from peak

-63.95%

-2.19%

-61.76%

Average Drawdown

Average peak-to-trough decline

-17.89%

-10.70%

-7.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.75%

2.10%

+29.65%

Volatility

NVO vs. ^GSPC - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 9.48% compared to S&P 500 Index (^GSPC) at 3.13%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVO^GSPCDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.48%

3.13%

+6.35%

Volatility (6M)

Calculated over the trailing 6-month period

37.43%

10.04%

+27.39%

Volatility (1Y)

Calculated over the trailing 1-year period

51.79%

12.62%

+39.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.58%

16.98%

+21.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.63%

18.06%

+14.57%

Frequently Asked Questions


NVO and ^GSPC have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVO has higher volatility (9.48%) compared to ^GSPC (3.13%). In terms of maximum drawdown, NVO dropped -74.70% vs ^GSPC's -56.78%.

^GSPC currently has the higher Sharpe Ratio (1.45 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVO and ^GSPC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer